VistaGen Therapeutics
VTGN
VTGN
105 hedge funds and large institutions have $360M invested in VistaGen Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 11 closing their positions.
Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
35
Reduced
30
Closed
11
Calls
$50K
Puts
$704K
Net Calls
-$654K
Net Calls Change
-$654K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$21.5M |
| 2 |
CC
2
Commodore Capital
New York
|
$14M |
| 3 |
3
Goldman Sachs
New York
|
$4.45M |
| 4 |
EGI
4
EAM Global Investors
Solana Beach,
California
|
$1.74M |
| 5 |
5
Two Sigma Advisers
New York
|
$3.04M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$35.4M |
| 2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$1.65M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$10.5M |
| 4 |
SB
4
Samsara BioCapital
Palo Alto,
California
|
$1.34M |
| 5 |
SSA
5
Schonfeld Strategic Advisors
New York
|
$1.16M |
